Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

Jamie Baumgartner, Jonathan Grinstein, and John Wilkerson go behind the headlines to discuss the implications of personalized gene-editing therapies, more HHS policy and funding updates, and the ...

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.

The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities ...

Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations ...

Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...

At the 2025 edition of the International Society of Pharmaceutical Engineering (ISPE) Europe Annual Conference, held in ...